One exception to this trend is TEM8 expression in hepatitis B (HBV)-induced hepatocellular carcinoma in which ANTXR1 is hypothesized to act as a cellular receptor for HBV and transport unknown antineoplastic therapeutics within the cell [49]. Here, ANTXR1 is linked to hepatocellular carcinoma.